BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29382856)

  • 1. Dynamic cellular phynotyping defines specific mobilization mechanisms of human hematopoietic stem and progenitor cells induced by SDF1α versus synthetic agents.
    Monzel C; Becker AS; Saffrich R; Wuchter P; Eckstein V; Ho AD; Tanaka M
    Sci Rep; 2018 Jan; 8(1):1841. PubMed ID: 29382856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.
    Karpova D; Ritchey JK; Holt MS; Abou-Ezzi G; Monlish D; Batoon L; Millard S; Spohn G; Wiercinska E; Chendamarai E; Yang W; Christ S; Gehrs L; Schuettpelz LG; Dembowsky K; Pettit AR; Rettig MP; Bonig H; DiPersio JF
    Blood; 2017 May; 129(21):2939-2949. PubMed ID: 28400375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
    Mohty M; Ho AD
    Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
    Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
    Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying adhesion mechanisms and dynamics of human hematopoietic stem and progenitor cells.
    Burk AS; Monzel C; Yoshikawa HY; Wuchter P; Saffrich R; Eckstein V; Tanaka M; Ho AD
    Sci Rep; 2015 Mar; 5():9370. PubMed ID: 25824493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors.
    Khurana S; Melacarne A; Yadak R; Schouteden S; Notelaers T; Pistoni M; Maes C; Verfaillie CM
    Stem Cells; 2014 Nov; 32(11):3012-22. PubMed ID: 25069965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Dynamic Phenotyping for Testing Novel Mobilizing Agents.
    Tanaka M
    Methods Mol Biol; 2019; 2017():11-27. PubMed ID: 31197765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection.
    Johns JL; Borjesson DL
    Innate Immun; 2012 Jun; 18(3):418-28. PubMed ID: 21964802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.
    Wuchter P; Leinweber C; Saffrich R; Hanke M; Eckstein V; Ho AD; Grunze M; Rosenhahn A
    Cell Tissue Res; 2014 Feb; 355(2):315-26. PubMed ID: 24337688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 and mobilization of hematopoietic precursors.
    Rettig MP; Ramirez P; Nervi B; DiPersio JF
    Methods Enzymol; 2009; 460():57-90. PubMed ID: 19446720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.
    Sanchez-Aguilera A; Lee YJ; Lo Celso C; Ferraro F; Brumme K; Mondal S; Kim C; Dorrance A; Luo HR; Scadden DT; Williams DA
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9607-12. PubMed ID: 21606370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
    Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
    Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis.
    Zhang J; Ren X; Shi W; Wang S; Chen H; Zhang B; Wang Z; Zhou Y; Chen L; Zhang R; Lv Y; Zhou J; Nan X; He L; Yue W; Li Y; Pei X
    Blood; 2014 Jan; 123(3):428-41. PubMed ID: 24196072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4.
    Chang CH; Hale SJ; Cox CV; Blair A; Kronsteiner B; Grabowska R; Zhang Y; Cook D; Khoo CP; Schrader JB; Kabuga SB; Martin-Rendon E; Watt SM
    Stem Cells; 2016 Jun; 34(6):1664-78. PubMed ID: 26866290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugates.
    Berchanski A; Kalinkovich A; Ludin A; Lapidot T; Lapidot A
    FEBS J; 2011 Nov; 278(21):4150-65. PubMed ID: 21910828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.
    Singh P; Mohammad KS; Pelus LM
    Stem Cells; 2020 Jul; 38(7):849-859. PubMed ID: 32159901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
    Bonig H; Chudziak D; Priestley G; Papayannopoulou T
    Exp Hematol; 2009 Mar; 37(3):402-15.e1. PubMed ID: 19157683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization.
    Liu W; Du W; Shang X; Wang L; Evelyn C; Florian MC; A Ryan M; Rayes A; Zhao X; Setchell K; Meller J; Guo F; Nassar N; Geiger H; Pang Q; Zheng Y
    Leukemia; 2019 Mar; 33(3):749-761. PubMed ID: 30254339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
    Ramirez P; Rettig MP; Uy GL; Deych E; Holt MS; Ritchey JK; DiPersio JF
    Blood; 2009 Aug; 114(7):1340-3. PubMed ID: 19571319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.